The goals of this proposal relate to the action of alpha1 adrenergic receptors in smooth muscle with particular emphasis on mechanisms by which catecholamines induce desensitization of alpha1 receptor-mediated responses. Desensitization refers to loss in responsiveness of a tissue after prolonged exposure to an agonist drug or hormone. We have demonstrated that several adaptations in blood vessels contribute to desensitization of alpha1 receptor-mediated smooth muscle contraction after prolonged exposure to catecholamines. this application proposes to investigate further the molecular basis underlying these changes in function. We have found that prolonged activation of alpha receptors induces the endothelium of vascular smooth muscle to release enhanced amounts of endothelial derived relaxing factor (EDRF); the alpha receptor subtype on endothelial cells (alpha1A vs alpha1B; or alpha2) which transduces this effect will be determined. The explanation for the enhanced release of EDRF induced by catecholamines will be sought by determining the expression of the nitric oxide synthase gene in endothelial cells in response to catecholamines to determine if catecholamines induce nitric oxide synthase as has been found to occur for various cytokines. The pathophysiological significance of enhanced release of EDRF induced by catecholamines will be determined in two rat models, one of pheochromocytoma (a norepinephrine-secreting tumor) and after prolonged infusions of vasopressors commonly used in the treatment of cardiovascular shock. We have found that prolonged alpha1 adrenergic receptor stimulation leads to down-regulation of protein kinase C in vascular smooth muscle; the mechanism for changes in expression of various protein kinase C isoforms found in smooth muscle will be determined. Potential alterations in the turnover of protein kinase C isozymes and the expression of their genes in desensitized smooth muscle cells will be sought. We will investigate the effects of prolonged activation of alpha1 receptors on expression of alpha1B receptors in cultured rat aorta smooth muscle cells. Based on our preliminary data, additional studies relating to the action of alpha1 receptors are proposed. Activation of protein kinase C in smooth muscle cells leads to enhanced expression of alpha1 receptors; we propose to determine the basis for this important regulatory change by investigation of the structure of the 5' regulatory region of the alpha1B adrenergic receptor gene. Stimulation of alpha1 receptors leads to activation of expression of the c-fos gene in rat aorta. We propose to investigate the role of desensitization of smooth muscle contraction on adrenergic receptor- mediated induction of expression of c-fos and the effects of EDRF on this response. These latter studies have implications for the effects of alpha1 agonists and angiotensin II on smooth muscle cell growth.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL041315-06
Application #
2219982
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1988-07-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Chen, Jin; Hoffman, Brian B; Isseroff, R Rivkah (2002) Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism. J Invest Dermatol 119:1261-8
Hu, Zhuo-Wei; Kerb, Reinhold; Shi, Xiao-You et al. (2002) Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 303:563-73
Hu, Z W; Hoffman, B B (2000) Nuclear run-on assays for measurement of adrenergic receptor transcription rate. Methods Mol Biol 126:169-80
Hu, Z W; Shi, X Y; Lin, R Z et al. (1999) alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. J Pharmacol Exp Ther 290:28-37
Hu, Z W; Shi, X Y; Lin, R Z et al. (1999) Contrasting signaling pathways of alpha1A- and alpha1B-adrenergic receptor subtype activation of phosphatidylinositol 3-kinase and Ras in transfected NIH3T3 cells. Mol Endocrinol 13:3-14
Chen, J; Lin, R; Hu, Z W et al. (1999) alpha1-adrenergic receptor activation of c-fos expression in transfected rat-1 fibroblasts: role of Ca2+. J Pharmacol Exp Ther 289:1376-84
Hu, Z W; Shi, X Y; Hoffman, B B (1998) Doxazosin inhibits proliferation and migration of human vascular smooth-muscle cells independent of alpha1-adrenergic receptor antagonism. J Cardiovasc Pharmacol 31:833-9
Lin, R Z; Chen, J; Hu, Z W et al. (1998) Phosphorylation of the cAMP response element-binding protein and activation of transcription by alpha1 adrenergic receptors. J Biol Chem 273:30033-8
Lin, R Z; Hu, Z W; Chin, J H et al. (1997) Heat shock activates c-Src tyrosine kinases and phosphatidylinositol 3-kinase in NIH3T3 fibroblasts. J Biol Chem 272:31196-202
Okazaki, M; Hu, Z W; Fujinaga, M et al. (1996) Alpha 1 adrenergic receptor activation of proto-oncogene expression in arterial smooth muscle: regulation by nitric oxide and vascular injury. Recept Signal Transduct 6:165-78

Showing the most recent 10 out of 28 publications